Disubstituted azepan orexin receptor antagonists

Details for Australian Patent Application No. 2009307921 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Cox, Christopher D.; Fraley, Mark E.; Schreier, John D.

Agent Spruson & Ferguson

Pub. Number AU-A-2009307921

PCT Pub. Number WO2010/048017

Priority 61/196,848 21.10.08 US

Filing date 15 October 2009

Wipo publication date 29 April 2010

International Classifications

A01N 43/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/00 (2006.01)

C07D 223/12 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/048017 Priority application(s): WO2010/048017

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307922-Treatment of neuroblastoma with multiarm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin

2009307920-2,3-disubstituted piperidine orexin receptor antagonists